Skip to content

Qiagen Weighs Stake Sale in $1 Billion Bioinformatics Arm

  • Diagnostics group is working with an adviser to weigh options
  • Business is likely to draw interest from private equity firms

Qiagen NV is weighing the sale of a minority stake in its bioinformatics division, which could value that business at more than $1 billion, people familiar with the matter said. 

The Dutch diagnostics firm is working with a financial adviser as it explores bringing in an investor, according to the people. Selling a stake in the unit, which provides software for analyzing biological data, could help fund further growth in this business, the people said.